India's Indoco Remedies slides after FDA inspection ends with seven observations

INDOCO REMEDIES

07/09/2026 05:07

** Shares of Indoco Remedies INRM.NS down 3.2% to 254.2 rupees 
** Co says U.S. Food and Drug Administration completed inspection at its Goa manufacturing facility, and issued seven form 483 observations
** Form 483 flags conditions that may violate U.S. FDA standards
** Stock on track for three straight sessions of fall
** YTD, INRM up ~8%

 (Reporting by Anuran Sadhu in Bengaluru)
 ((Anuran.Sadhu@thomsonreuters.com; +91 8697274436;))